Reid, Fiona M. http://orcid.org/0000-0002-6029-7948
Aucott, Lorna
Glazener, Cathryn M. A.
Elders, Andrew
Hemming, Christine
Cooper, Kevin G.
Freeman, Robert M.
Smith, Anthony R. B.
Hagen, Suzanne
Kilonzo, Mary
Boyers, Dwayne
MacLennan, Graeme
Norrie, John
Breeman, Suzanne
,
Article History
Received: 25 April 2022
Accepted: 24 June 2022
First Online: 26 August 2022
Declarations
:
: PROSPECT was approved by the North of Scotland Research Ethics Committee (NOSRES) on 7th July 2009 (REC reference number 09/SO802/56).
: Professor Freeman reports previous (not in the last 5-years) speaker fees for Astellas and Pfizer. All other authors declare that they have no conflict of interest.Mary Kilonzo is the current Health Economics Editor of the Cochrane Incontinence Group.Professor Norrie declares grants from University of Aberdeen and grants from University of Edinburgh during the conduct of the study and membership of the following NIHR boards: Efficacy and Mechanism Evaluation (EME) Board; CPR decision-making committee; HTA Commissioning Board; HTA Commissioning Sub-Board (EOI); HTA Funding Boards Policy Group; HTA General Board; HTA Post-Board funding teleconference; NIHR CTU Standing Advisory Committee; NIHR HTA & EME Editorial Board; Pre-exposure Prophylaxis Impact Review Panel.